The amygdala, panic disorder, and cardiovascular responses

Annals of the New York Academy of Sciences

Volumn 985, Issue , 2003, Pages 308-325

  Shekhar, Anantha ^a,d   Sajdyk, Tammy J ^a   Gehlert, Donald R ^b   Rainnie, Donald G ^c  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Corticotropin releasing factor (CRF); GABA; Lactate infusions; LTP; Priming

Indexed keywords

ANGIOTENSIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; LACTIC ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ADRENERGIC SYSTEM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; AUTONOMIC NERVOUS SYSTEM; AVOIDANCE BEHAVIOR; CARDIOVASCULAR RESPONSE; CONDITIONING; CONFERENCE PAPER; EMOTION; FEAR; GABAERGIC SYSTEM; INHIBITION KINETICS; NERVE CELL PLASTICITY; NONHUMAN; PANIC; RAT; REGULATORY MECHANISM; STRESS;

ANIMALIA;

EID: 0037279890     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07090.x     Document Type: Conference Paper

References (94)

1. KESSLER, R.C. et al. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51: 8-19.
2. MAGEE, W.J. et al. 1996. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch. Gen. Psychiatry 53: 159-168.
3. WEISSMAN, M.M. & K.R. MERIKANGAS. 1986. The epidemiology of anxiety and panic disorders: an update. J. Clin. Psychiatry 47(Suppl): 11-17.
4. GOETZ, R.R., D.F. KLEIN & J.M. GORMAN. 1996. Symptoms essential to the experience of sodium lactate-induced panic. Neuropsychopharmacology 14: 355-366.
5. 2 and hyperventilation in patients with panic disorder. Am. J. Psychiatry 151: 547-553.
6. KLEIN, D.F. 1993. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch. Gen. Psychiatry 50: 306-317.
7. Shekhar, A., T.J. Sajdyk & A.W. Goddard. 2002. Neurobiology of panic disorder. Trends Economics Neurobiol. 4: 36-41.
8. SINGEWALD, N. & T. SHARP. 2000. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98: 759-770.
9. SHEKHAR, A. et al. 1994. Fear-potentiated startle elevates catecholamine levels in the dorsomedial hypothalamus of rats. Pharmacol. Biochem. Behav. 48: 525-529.
10. SHEKHAR, A., J.R. SIMON & W.J. MCBRIDE. 1996. Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions. Pharmacol. Biochem. Behav. 55: 249-256.
11. HILTON, S.M. 1963. Amygdaloid region for defence reactions and its efferent pathway to the brainstem. J. Physiol. 165: 160-173.
12. KAADA, B. 1972. Stimulation and regional ablation of the amygdaloid complex with reference to functional representation. In The Neurobiology of the Amygdala. B. Eleftheriou, Ed.:205-281. Plenum Press. New York.
13. KAPP, W.P., W.F. SUPPLE & J.P. PASCOE. 1992. Amygdaloid contribution to conditioned arousal and sensory information processing. In The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. J. Aggleton, Ed.:229-254. Wiley-Liss. New York.
14. LEDOUX, J. 1992. Emotion and the amygdala. In The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. J. Aggleton, Ed.:339-351. Wiley-Liss. New York.
15. DAVIS, M. 1992. The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol. Sci. 13: 35-41.
16. ADOLPHS, R. et al. 1994. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 372: 669-672.
17. ADOLPHS, R. et al. 1995. Fear and the human amygdala. J. Neurosci. 15: 5879-5891.
18. A receptors in the basolateral amygdala of rats regulate "anxiety." Pharmacol. Biochem. Behav. 37: 701-706.
19. MORRIS, J.S. et al. 1996. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 383: 812-815.
20. GRAY, J. 1987. The Neuropsychology of Anxiety. Oxford. Oxford University Press.
21. REIMAN, E.M. et al. 1984. A focal brain abnormality in panic disorder, a severe form of anxiety. Nature 310: 683-685.
22. CHARNEY, D.S. et al. 1992. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiat. Scandinav. 86: 273-282.
23. TARGUM, S.D. 1992. Cortisol response during different anxiogenic challenges in panic disorder patients. Psychoneuroendocrinology 17: 453-458.
24. PRICE, G.A., L.C. BARR & W.K. GOODMAN. 1995. Pharmacological challenges in anxiety disorder. In Psychopharmacology: Fourth Generation of Progression. F.E. Bloom & D.J. Kupfer, Eds.:1311-1323. Raven Press. New York.
25. ASTON-JONES, G. et al. 1996. Role of the locus coeruleus in emotional activation. Prog. Brain Res. 107: 379-402.
26. FEINDEL, P.W. 1954. Localization of discharge in temporal lobe automatism. Arch. Neurol. Psychol. 72: 605-630.
27. NARABAYASHI, N.T., Y. SAITO, M. YOSHIDA & M. NAGAHATA. 1963. Sterotaxic amygdalotomy for behavior disorders. Arch. Neurol. 9: 1-16.
28. GELSEMA, A.J., D.J. MCKITRICK & F.R. CALARESU. 1987. Cardiovascular responses to chemical and electrical stimulation of amygdala in rats. Am. J. Physiol. 253: R712-718.
29. MASKATI, Z. 1989. Cardiovascular and motor components of the defense reaction elicited in rats by electrical and chemical stimilation in amygdala. J. Autonom. Nerv. Syst. 28: 127-132.
30. SanDERS, S.K. & A. SHEKHAR. 1991. Blockade of GABAA receptors in the region of the anterior basolateral amygdala of rats elicits increases in heart rate and blood pressure. Brain Res. 567: 101-110.
31. SHIBATA, K. et al. 1982. Localization of the site of the anticonflict action of benzodiazepines in the amygdaloid nucleus of rats. Brain Res. 234: 442-446.
32. NAVY, J. & L. DECSI. 1973. Location of the site of the tranquillizing action of diazepam by intralimbic application. Neuropharmacology 12: 757-768.
33. NAGY, J., K. ZAMBO & L. DECSI. 1979. Anti-anxiety action of diazepam after intra-amygdaloid application in the rat. Neuropharmacology 18: 573-576.
34. PETERSEN, E.N., C. BRAESTRUP & J. SCHEEL-KRUGER. 1985. Evidence that the anticonflict effect of midazolam in amygdala is mediated by the specific benzodiazepine receptors. Neurosci. Lett. 53: 285-288.
35. HODGES, H., S. GREEN & B. GLENN. 1987. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology 92: 491-504.
36. SANDERS, S.K. & A. SHEKHAR. 1995. Anxiolytic effects of chlordiazepoxide blocked by injection of GABAA and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biol. Psychiatry 37: 473-476.
37. NIEHOFF, D.L. & M.J. KUHAR. 1983. Benzodiazepine receptors: localization in rat amygdala. J. Neurosci. 3: 2091-2097.
38. SCHEEL-KRUGEK, J. & E.N. PETERSEN. 1982. Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala. Eur. J. Pharmacol. 82: 115-116.
39. HITCHCOCK, J. & M. DAVIS. 1986. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm. Behav. Neurosci. 100: 11-22.
40. MISERENDINO, M.J. et al. 1990. Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345: 716-718.
41. KAPP, P.J. & M.A. BIXLER. 1984. The amygdala: a neuroanatomical systems approach to its contribution to aversive conditioning. In The Neuropsychology of Memory. L.S. Butters, Ed.:473-488. Guilford Press. New York.
42. DAVIS, M. 1986. Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. Behav. Neurosci. 100: 814-824.
43. LEDOUX, J.E. et al. 1988. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8: 2517-2529.
44. CAMPEAU, S. & M. DAVIS. 1995. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J. Neurosci. 15: 2301-2311.
45. LEDOUX, J.E., C. FARB & D.A. RUGGIERO. 1990. Topographic organization of neurons in the acoustic thalamus that project to the amygdala. J. Neurosci. 10: 1043-1054.
46. MCDONALD, A.J. & J.C. PEARSON. 1989. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci. Letts. 100: 53-58.
47. MCDONALD, A.J. 1992. Cell types and intrinsic connections of the amygdala, in The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. J. Aggleton, Ed.:67-96. Wiley-Liss. New York.
48. MCDONALD, A.J. 1982. Neurons of the lateral and basolateral amygdaloid nuclei: a Golgi study in the rat. J. Comp. Neurol. 212: 293-312.
49. MCDONALD, A.J. 1994. Neuronal localization of glutamate receptor subunits in the basolateral amygdala. NeuroReport 6: 13-16.
50. PRICE, R.F. & D.G. AMARAL. 1987. The limbic region II: the amygdaloid complex. In Handbook of Chemical Neuroanatomy. T.H. Bjorklund & L.W. Swanson, Eds.:279-388. Elsevier. Amsterdam.
51. RAINNIE, D.G., E.K. ASPRODINI & P. SHINNICK-GALLAGHER. 1991. Inhibitory transmission in the basolateral amygdala. J. Neurophysiol. 66: 999-1009.
52. RAINNIE, D.G., E.K. ASPRODINI & P. SHINNICK-GALLAGHER. 1991. Excitatory transmission in the basolateral amygdala. J. Neurophysiol. 66: 986-998.
53. MCDONALD, A.J. 1985. Immunohistochemical identification of gamma-aminobutyric acid-containing neurons in the rat basolateral amygdala. Neurosci. Letts. 53: 203-207.
54. SAJDYK, T.J. & A. SHEKHAR. 2000. Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala. Eur. J. Pharmacol. 394: 265-273.
55. SANDERS, S.K., S.L. MORZORATI & A. SHEKHAR. 1995. Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala. Brain Res. 699: 250-259.
56. DESOUZA, I.T., M.H. PERRIN, J. RIVIER, et al. 1985. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 5: 3189-3203.
57. VALE, W. et al. 1981. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394-1397.
58. RIVIER, C.L. & P.M. PLOTSKY. 1986. Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Ann. Rev. Physiol. 48: 475-494.
59. DUNN, A.J. & C.W. BERRIDGE. 1990. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res.- Brain Res. Rev. 15: 71-100.
60. BRITTON, K.T. et al. 1985. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology 86: 170-174.
61. BRITTON, K.T. et al. 1986. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci. 39: 1281-1286.
62. DUNN A.J. & S.E. FILE. 1987. Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm. Behav. 21: 193-202.
63. SWERDLOW, N.R. et al. 1986. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology 88: 147-152.
64. FILE, J.A. & H.A. BALDWIN. 1988. Anxiolytic and anxiogenic drugs: changes in behavioral and endocrine resoponses. Stress Med. 4: 221-230.
65. STENZEL-POORE, H.S., S. RIVEST, G.F. KOOB & W.W. VALE. 1994. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14: 2579-2584.
66. VAUGHAN, J. et al. 1995. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292.
67. BEHAN, D.P. et al. 1996. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free" CRF levels in human brain. Brain Res 725: 263-267.
68. ASABA, K., S. MAKINO & K. HASHIMOTO. 1998. Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone. Brain Res. 806: 95-103.
69. MOREAU, J.L., G. KILPATRICK & F. JENCK. 1997. Urocortin, a novel neuropeptide with anxiogenic-like properties. NeuroReport 8: 1697-1701.
70. BROWN, T.H. et al. 1988. Long-term synaptic potentiation. Science 242: 724-728.
71. MAREN, S. 1999. Long-term potentiation in the amygdala: a mechanism for emotional learning and memory. Trends Neurosci. 22: 561-567.
72. CHAPMAN, P.F. et al. 1990. Long-term synaptic potentiation in the amygdala. Synapse 6: 271-278.
73. CHAPMAN, P.F. & L.L. BELLAVANCE. 1992. Induction of long-term potentiation in the basolateral amygdala does not depend on NMDA receptor activation. Synapse 11: 310-318.
74. CLUGNET, M.C. & J.E. LEDOUX. 1990. Synaptic plasticity in fear conditioning circuits: induction of LTP in the lateral nucleus of the amygdala by stimulation of the medial geniculate body. J. Neurosci. 10: 2818-2824.
75. COLLINGRIDGE, G.L., S.J. KEHL & H. MCLENNAN. 1983. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334: 33-46.
76. TEYLER, T.J. & P. DISCENNA. 1984. Long-term potentiation as a candidate mnemonic device. Brain Res. 319: 15-28.
77. LEDOUX, J.E. et al. 1990. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J. Neurosci. 10: 1062-1069.
78. ROGAN, M.T., U.V. STAUBLI & J.E. LEDOUX. 1997. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390: 604-607.
79. MCKERNAN, M.G. & P. SHINNICK-GALLAGHER. 1997. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390: 607-611.
80. SAJDYK, T.J. et al. 1999. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav. Brain Res. 100: 207-215.
81. THIELEN, S.K. & A. SHEKHAR. 2002. Amygdala priming results in conditioned place avoidance. Pharmacol. Biochem. Behav.71: 401-406.
82. HUANG, Y.Y., K.C. MARTIN & E.R. KANDEL. 2000. Both protein kinase A and mitogenactivated protein kinase are required in the amygdala for the macromolecular synthesis-dependent late phase of long-term potentiation. J. Neurosci. 20: 6317-6325.
83. MCGAUGH, J.L. 2000. Memory: a century of consolidation. Science 287: 248-251.
84. HUANG, Y.Y. & E.R. KANDEL. 1998. Postsynaptic induction and PKA-dependent expression of LTP in the lateral amygdala. Neuron 21: 169-178.
85. GOOSENS, K.A., W. HOLT & S. MAREN. 2000. A role for amygdaloid PKA and PKC in the acquisition of long-term conditional fear memories in rats. Behav. Brain Res. 114: 145-152.
86. 2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc. Natl. Acad. Sci. USA 96: 3269-3274.
87. JOHNSON, A.K. & P.M. GROSS. 1993. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 7: 678-686.
88. SHEKHAR, A. & S.R. KEIM. 1997. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J. Neurosci. 17: 9726-9735.
89. BUGGY, J. et al. 1979. Osmosensitivity of rat third ventricle and interactions with angiotensin. Am. J. Physiol. 236: R75-82.
90. THRASHER, T.N. & L.C. KEIL. 1987. Regulation of drinking and vasopressin secretion: role of organum vasculosum laminae terminalis. Am. J. Physiol. 253: R108-120.
91. KOVACS, K.J. & P.E. SAWCHENKO. 1993. Mediation of osmoregulatory influences on neuroendocrine corticotropin-releasing factor expression by the ventral lamina terminalis. Proc. Natl. Acad. Sci. USA 90: 7681-7685.
92. RICHARD, D. & C.W. BOURQUE. 1992. Synaptic activation of rat supraoptic neurons by osmotic stimulation of the organum vasculosum lamina terminalis. Neuroendocrinology 55: 609-611.
93. SHEKHAR, A. et al. 1999. Role of the basolateral amygdala in panic disorder. Ann. N.Y. Acad. Sci. 877: 747-750.
94. GEHLERT, D.R., S.L. GACKENHEIMER & D.A. SCHOBER. 1991. Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain. Neuroscience 44: 501-514.